Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2011

01-01-2011 | Letter to the Editor

Cytomegalovirus and Epstein–Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation

Authors: Shu-Yi Tsao, Kung-Chao Chang, Ya-Ping Chen, Yu-Min Yeh, Wu-Chou Su, Tsai-Yun Chen

Published in: Annals of Hematology | Issue 1/2011

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Gottschalk S, Rooney CM, Heslop HE (2005) Post-transplant lymphoproliferative disorders. Annu Rev Med 56:29–44CrossRefPubMed
2.
Opelz G, Daniel V, Naujokat C, Fickenscher H, Dohler B (2007) Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol 8:212–218CrossRefPubMed
3.
Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, Dummer S, Ho M (1997) Posttransplant lymphoproliferative disease in primary Epstein–Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 176:1462–1467CrossRefPubMed
4.
Mattila PS, Aalto SM, Heikkila L, Mattila S, Nieminen M, Auvinen E, Hedman K, Tarkkanen J (2001) Malignancies after heart transplantation: presence of Epstein–Barr virus and cytomegalovirus. Clin Transplant 15:337–342CrossRefPubMed
5.
Vila L, Moreno L, Andres MM, Fernandez JM, Verdeguer A, Perez-Valle S, Sanguesa C, Berbel O, Castel V (2008) Could other viruses cause pediatric posttransplant lymphoproliferative disorder? Clin Transl Oncol 10:422–425CrossRefPubMed
6.
Paraskevas S, Coad JE, Gruessner A, Kandaswamy R, Humar A, Sutherland DE, Gruessner RW (2005) Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience. Transplantation 80:613–622CrossRefPubMed
7.
Hou HA, Yao M, Tang JL, Chen YK, Ko BS, Huang SY, Tien HF, Chang HH, Lu MY, Lin TT, Lin KH, Hsiao CH, Lin CW, Chen YC (2009) Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years’ experience in a single institute. Bone Marrow Transplant 43:315–321CrossRefPubMed
8.
Brion A, Cahn JY, Mougin C, Angonin R, Flesch M, Deschaseaux ML, Plouvier E, Deconinck E, Voillat L, Racadot E, Carbillet JP, Herve P (1995) Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six cases. Nouv Rev Fr Hematol 37:289–296PubMed
9.
Swerdlow SH, Harris NL, Jaffe ES, Pileri SA (2008) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer (IARC) 343–349
10.
Frey NV, Tsai DE (2007) The management of posttransplant lymphoproliferative disorder. Med Oncol 24:125–136CrossRefPubMed
Metadata
Title
Cytomegalovirus and Epstein–Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
Authors
Shu-Yi Tsao
Kung-Chao Chang
Ya-Ping Chen
Yu-Min Yeh
Wu-Chou Su
Tsai-Yun Chen
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/2011
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-0947-8

Other articles of this Issue 1/2011

Annals of Hematology 1/2011 Go to the issue

Original Article

Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients—a randomized placebo-controlled trial

Original Article

Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim

Original Article

Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin’s lymphoma

Review Article

Iron overload in MDS—pathophysiology, diagnosis, and complications

Letter to the Editor

Acquired haemophilia in a patient with discoid lupus

Original Article

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits